Skip to main content
Top

Open Access 03-02-2025 | Atrial Fibrillation | ORIGINAL RESEARCH

Near-zero fluoroscopy workflow for pulmonary vein isolation in atrial fibrillation using a variable loop, 3D-integrated circular PFA catheter (Varipulse™): initial single-center experience with the first 35 patients

Authors: M. Borlich, S. Groschke, J. Wietgrefe, F. Witt, A. Paulssen, S. Fichtlscherer, A. Elsässer, H. Nef, L. Iden

Published in: Journal of Interventional Cardiac Electrophysiology

Login to get access

Abstract

Background

Catheter ablation is a standard atrial fibrillation (AF) treatment, traditionally using radiofrequency (RF) or cryoablation, which carries the risk of damaging nearby structures. Pulsed field ablation (PFA) offers partly tissue-selective energy application with minimal collateral damage. This study evaluated a near-zero fluoroscopy workflow with the novel VARIPULSE™ catheter, combining advanced mapping for optimized PFA delivery and reduced radiation. Here, we investigate the safety, efficiency, and effectiveness of this approach in the first 35 patients treated.

Objective

This study aimed to assess the procedural characteristics, safety, and acute efficacy of pulmonary vein isolation (PVI) using the VARIPULSE™ PFA catheter in patients with AF, while specifically evaluating a near-zero fluoroscopy workflow to minimize radiation exposure during the procedure.

Methods

Thirty-five consecutive patients with paroxysmal or persistent AF underwent pulmonary vein isolation (PVI) using the VARIPULSE™ PFA catheter. Procedures were conducted under general anesthesia or deep sedation. Key procedural endpoints included acute pulmonary vein isolation, total procedure time, left atrial (LA) dwell time, fluoroscopy time and dose, and safety outcomes, with a focus on assessing the feasibility of a near-zero fluoroscopy workflow.

Results

Thirty patients underwent near-zero fluoroscopy atrial fibrillation ablation using the novel VARIPULSE™ Pulsed Field Ablation catheter. Patients had a median age of 70 years and typical cardiovascular comorbidities, with 54% presenting with paroxysmal AF. Thirty-three of 35 patients (94%) had a normal left ventricular systolic function (> 60%). The median CHA2DS2-VA score was 2 (IQR 1–3.75). Sinus rhythm was observed in 66% of cases at procedure start. Median fluoroscopy time was 0.8 min, total median procedure time 53 min, median LA dwell time 38 min, and median fluoroscopy dose 20.4 µGym2. Pulmonary vein isolation was achieved in 100% of cases without radiofrequency touch-up. No major complications occurred.

Conclusion

The VARIPULSE™ Pulsed Field Ablation system enables an efficient, nearly fluoroscopy-free atrial fibrillation ablation with a simple, easily integrable workflow in the electrophysiology lab. Complete pulmonary vein isolation was achieved in all cases without radiofrequency touch-ups, and the procedure was safe with no major complications. This demonstrates the potential for widespread adoption of this technology and workflow.

Graphical abstract

Literature
1.
go back to reference Van Gelder IC, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314–414. Van Gelder IC, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314–414.
2.
go back to reference Andrade JG, et al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. J Cardiovasc Electrophysiol. 2014;25(2):187–94.CrossRefPubMed Andrade JG, et al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. J Cardiovasc Electrophysiol. 2014;25(2):187–94.CrossRefPubMed
3.
go back to reference Bunch TJ, et al. Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol. 2005;16(12):1318–25.CrossRefPubMed Bunch TJ, et al. Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol. 2005;16(12):1318–25.CrossRefPubMed
4.
go back to reference Shehadeh M, et al. Esophageal injury, perforation, and fistula formation following atrial fibrillation ablation. J Interv Card Electrophysiol. 2024;67(2):409–24.CrossRefPubMed Shehadeh M, et al. Esophageal injury, perforation, and fistula formation following atrial fibrillation ablation. J Interv Card Electrophysiol. 2024;67(2):409–24.CrossRefPubMed
5.
go back to reference Tilz RR, et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023;44(27):2458–69.CrossRefPubMedPubMedCentral Tilz RR, et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023;44(27):2458–69.CrossRefPubMedPubMedCentral
6.
go back to reference Yavin H, et al. Circular multielectrode pulsed field ablation catheter Lasso pulsed field ablation: lesion characteristics, durability, and effect on neighboring structures. Circ Arrhythm Electrophysiol. 2021;14(2):e009229.CrossRefPubMedPubMedCentral Yavin H, et al. Circular multielectrode pulsed field ablation catheter Lasso pulsed field ablation: lesion characteristics, durability, and effect on neighboring structures. Circ Arrhythm Electrophysiol. 2021;14(2):e009229.CrossRefPubMedPubMedCentral
7.
go back to reference Yavin H, et al. Pulsed field ablation using a lattice electrode for focal energy delivery: biophysical characterization, lesion durability, and safety evaluation. Circ Arrhythm Electrophysiol. 2020;13(6):e008580.CrossRefPubMedPubMedCentral Yavin H, et al. Pulsed field ablation using a lattice electrode for focal energy delivery: biophysical characterization, lesion durability, and safety evaluation. Circ Arrhythm Electrophysiol. 2020;13(6):e008580.CrossRefPubMedPubMedCentral
8.
go back to reference Koruth J, et al. Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol. 2019;12(12):e007781.CrossRefPubMedPubMedCentral Koruth J, et al. Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol. 2019;12(12):e007781.CrossRefPubMedPubMedCentral
9.
go back to reference Ekanem E, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 2024;30(7):2020–9.CrossRefPubMedPubMedCentral Ekanem E, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 2024;30(7):2020–9.CrossRefPubMedPubMedCentral
10.
go back to reference Nair DG, Gomez T, De Potter T. VARIPULSE: a step-by-step guide to pulmonary vein isolation. J Cardiovasc Electrophysiol. 2024;35(9):1817–27.CrossRefPubMed Nair DG, Gomez T, De Potter T. VARIPULSE: a step-by-step guide to pulmonary vein isolation. J Cardiovasc Electrophysiol. 2024;35(9):1817–27.CrossRefPubMed
11.
go back to reference Hsu JC, et al. Comprehensive dose-response study of pulsed field ablation using a circular catheter compared with radiofrequency ablation for pulmonary vein isolation: A preclinical study. Heart Rhythm O2. 2023;4(10):662–7.CrossRefPubMedPubMedCentral Hsu JC, et al. Comprehensive dose-response study of pulsed field ablation using a circular catheter compared with radiofrequency ablation for pulmonary vein isolation: A preclinical study. Heart Rhythm O2. 2023;4(10):662–7.CrossRefPubMedPubMedCentral
12.
go back to reference Duytschaever M, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16(3):e011780.CrossRefPubMedPubMedCentral Duytschaever M, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16(3):e011780.CrossRefPubMedPubMedCentral
14.
go back to reference Bourier F, et al. Evaluation of a new very low dose imaging protocol: feasibility and impact on X-ray dose levels in electrophysiology procedures. Europace. 2016;18(9):1406–10.CrossRefPubMed Bourier F, et al. Evaluation of a new very low dose imaging protocol: feasibility and impact on X-ray dose levels in electrophysiology procedures. Europace. 2016;18(9):1406–10.CrossRefPubMed
15.
go back to reference Sommer P, et al. Practical guidance to reduce radiation exposure in electrophysiology applying ultra low-dose protocols: a European Heart Rhythm Association review. Europace. 2023;25(7):euad191. Sommer P, et al. Practical guidance to reduce radiation exposure in electrophysiology applying ultra low-dose protocols: a European Heart Rhythm Association review. Europace. 2023;25(7):euad191.
16.
go back to reference Reddy VY, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–27.CrossRefPubMed Reddy VY, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–27.CrossRefPubMed
17.
go back to reference Reddy VY, et al. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol. 2023;9(8 Pt 3):1786–801.CrossRefPubMed Reddy VY, et al. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol. 2023;9(8 Pt 3):1786–801.CrossRefPubMed
18.
go back to reference Mohanty S, et al. Redefining the blanking period after pulsed-field ablation in patients with atrial fibrillation. Heart Rhythm. 2024;S1547–5271(24):03117–5. Mohanty S, et al. Redefining the blanking period after pulsed-field ablation in patients with atrial fibrillation. Heart Rhythm. 2024;S1547–5271(24):03117–5.
20.
go back to reference Della Rocca DG, et al. Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison. Europace. 2023;26(1):euae016. Della Rocca DG, et al. Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison. Europace. 2023;26(1):euae016.
Metadata
Title
Near-zero fluoroscopy workflow for pulmonary vein isolation in atrial fibrillation using a variable loop, 3D-integrated circular PFA catheter (Varipulse™): initial single-center experience with the first 35 patients
Authors
M. Borlich
S. Groschke
J. Wietgrefe
F. Witt
A. Paulssen
S. Fichtlscherer
A. Elsässer
H. Nef
L. Iden
Publication date
03-02-2025
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-025-01981-5

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now